Premium
Avanafil (Spedra): increasing the choice of PDE‐5 inhibitors
Author(s) -
Chaplin Steve
Publication year - 2014
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1229
Subject(s) - medicine , traditional medicine
Avanafil is a new PDE‐5 inhibitor for treating erectile dysfunction. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse effects.